Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $36,932 | 2 | 63.7% |
| Travel and Lodging | $19,598 | 13 | 33.8% |
| Food and Beverage | $1,453 | 10 | 2.5% |
| Education | $13.34 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $36,932 | 2 | $0 (2023) |
| Roche Products Limited | $10,539 | 3 | $0 (2018) |
| F. Hoffmann-La Roche AG | $9,509 | 12 | $0 (2019) |
| GENZYME CORPORATION | $1,003 | 8 | $0 (2019) |
| PFIZER INC. | $13.34 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18,182 | 1 | Genentech, Inc. ($18,182) |
| 2022 | $18,750 | 1 | Genentech, Inc. ($18,750) |
| 2020 | $13.34 | 1 | PFIZER INC. ($13.34) |
| 2019 | $2,287 | 11 | F. Hoffmann-La Roche AG ($1,642) |
| 2018 | $10,968 | 7 | Roche Products Limited ($10,539) |
| 2017 | $7,797 | 5 | F. Hoffmann-La Roche AG ($7,797) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/30/2023 | Genentech, Inc. | — | Grant | Cash or cash equivalent | $18,181.82 | General |
| 06/30/2022 | Genentech, Inc. | — | Grant | Cash or cash equivalent | $18,750.00 | General |
| 10/12/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $319.58 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $253.67 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $28.31 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $23.11 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $20.46 | General |
| 06/01/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: None | ||||||
| 03/13/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $670.05 | General |
| Category: None | ||||||
| 03/13/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $459.75 | General |
| Category: None | ||||||
| 03/13/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $355.51 | General |
| Category: None | ||||||
| 03/13/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $64.68 | General |
| Category: None | ||||||
| 03/13/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $64.62 | General |
| Category: None | ||||||
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $276.47 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $57.46 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $24.41 | General |
| 10/17/2018 | Roche Products Limited | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $9,975.52 | General |
| Category: None | ||||||
| 10/17/2018 | Roche Products Limited | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $429.41 | General |
| Category: None | ||||||
| 10/17/2018 | Roche Products Limited | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $133.94 | General |
| Category: None | ||||||
| 06/02/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $70.88 | General |
| Category: None | ||||||
| 10/20/2017 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 10/19/2017 | F. Hoffmann-La Roche AG | — | Travel and Lodging | In-kind items and services | $6,964.68 | General |
| 10/19/2017 | F. Hoffmann-La Roche AG | — | Travel and Lodging | In-kind items and services | $561.10 | General |
| 10/19/2017 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $231.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 62 | $54,790 | $8,733 |
| 2022 | 3 | 47 | 112 | $77,492 | $12,567 |
| 2021 | 2 | 50 | 82 | $52,965 | $8,876 |
| 2020 | 2 | 53 | 112 | $92,816 | $12,316 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 29 | 40 | $30,920 | $5,165 | 16.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $23,870 | $3,569 | 15.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 62 | $34,162 | $5,627 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 20 | 35 | $27,055 | $4,493 | 16.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $16,275 | $2,447 | 15.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 37 | 65 | $50,245 | $8,384 | 16.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 13 | 17 | $2,720 | $492.83 | 18.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 92 | $71,116 | $9,287 | 13.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 20 | 20 | $21,700 | $3,029 | 14.0% |
About David Oh
David Oh is a Hematology & Oncology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891084349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Oh has received a total of $57,997 in payments from pharmaceutical and medical device companies, with $18,182 received in 2023. These payments were reported across 26 transactions from 5 companies. The most common payment nature is "Grant" ($36,932).
As a Medicare-enrolled provider, Oh has provided services to 201 Medicare beneficiaries, totaling 368 services with total Medicare billing of $42,493. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location San Francisco, CA
- Active Since 04/06/2011
- Last Updated 11/14/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1891084349
Products in Payments
- Non-Covered Product (Drug) $12,251
- NO PRODUCT DISCUSSED (Drug) $1,003
- INLYTA (Drug) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in San Francisco
Dr. Terence Friedlander, Ms, MS
Hematology & Oncology — Payments: $248,592
Pamela Munster, Md, MD
Hematology & Oncology — Payments: $98,260
Dr. Caroline Behler, M.d., M.s, M.D., M.S
Hematology & Oncology — Payments: $64,653
Dr. Paul Volberding, Md, MD
Hematology & Oncology — Payments: $51,997
Dr. Alain Algazi, M.d, M.D
Hematology & Oncology — Payments: $24,175
Rebecca Olin, Md, MD
Hematology & Oncology — Payments: $14,579